|
|
|
|
| LEADER |
03548nma a2200889 u 4500 |
| 001 |
EB002173159 |
| 003 |
EBX01000000000000001310936 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230811 ||| eng |
| 020 |
|
|
|a books978-3-0365-7502-5
|
| 020 |
|
|
|a 9783036575025
|
| 020 |
|
|
|a 9783036575032
|
| 100 |
1 |
|
|a Kung, Woon-Man
|
| 245 |
0 |
0 |
|a Challenges and Perspectives of Neurological Disorders
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (146 p.)
|
| 653 |
|
|
|a myelin proteolipid protein
|
| 653 |
|
|
|a machine learning
|
| 653 |
|
|
|a neurohistiocytosis
|
| 653 |
|
|
|a radiomics
|
| 653 |
|
|
|a mitochondrial dysfunction
|
| 653 |
|
|
|a interferon
|
| 653 |
|
|
|a screening tool
|
| 653 |
|
|
|a Erdheim-Chester disease
|
| 653 |
|
|
|a histiocytosis
|
| 653 |
|
|
|a mild cognitive impairment
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a diagnosis
|
| 653 |
|
|
|a tau positron emission tomography
|
| 653 |
|
|
|a cognitive
|
| 653 |
|
|
|a endovascular treatment
|
| 653 |
|
|
|a MELAS
|
| 653 |
|
|
|a multiple sclerosis
|
| 653 |
|
|
|a reversible DWI hyperintensities
|
| 653 |
|
|
|a neurological
|
| 653 |
|
|
|a gross total resection
|
| 653 |
|
|
|a protein structure prediction
|
| 653 |
|
|
|a glioblastoma
|
| 653 |
|
|
|a Mild Cognitive Impairment
|
| 653 |
|
|
|a functional connectivity
|
| 653 |
|
|
|a virtual reality
|
| 653 |
|
|
|a amyotrophic lateral sclerosis
|
| 653 |
|
|
|a functional analysis
|
| 653 |
|
|
|a reocclusion
|
| 653 |
|
|
|a rehabilitation
|
| 653 |
|
|
|a NIID
|
| 653 |
|
|
|a residual stenosis
|
| 653 |
|
|
|a atherosclerotic
|
| 653 |
|
|
|a natural killer cells
|
| 653 |
|
|
|a cerebellar ataxia
|
| 653 |
|
|
|a Neurosciences / bicssc
|
| 653 |
|
|
|a NOTCH2NLC
|
| 653 |
|
|
|a neuronal intranuclear inclusion disease
|
| 653 |
|
|
|a intermediate-length repeats
|
| 653 |
|
|
|a metaverse
|
| 653 |
|
|
|a Alzheimer's disease
|
| 653 |
|
|
|a Alzheimer's Disease
|
| 653 |
|
|
|a Florzolotau PET
|
| 653 |
|
|
|a neuropsychological tests battery
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a deep learning radiomics
|
| 653 |
|
|
|a nucleotide repeat expansion
|
| 653 |
|
|
|a immune function
|
| 653 |
|
|
|a Tau PET
|
| 700 |
1 |
|
|a Ningrum, Dina Nur Anggraini
|
| 700 |
1 |
|
|a Kung, Woon-Man
|
| 700 |
1 |
|
|a Ningrum, Dina Nur Anggraini
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-7502-5
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/100778
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/7240
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 333
|
| 520 |
|
|
|a This reprint offers a comprehensive and updated overview of the current state-of-the-art techniques in the management of various neurological disorders. These disorders include neurodegenerative diseases, neurovascular disorders, and neuro-oncological diseases. The reprint also presents the latest advances and innovations in the diagnosis, treatment, and prevention of these complex conditions, emphasizing the role of cutting-edge technologies, such as neurobiology, neuroimaging, neuroinformatics, neuropharmacology, and neurosurgery. This reprint is a useful resource for researchers, clinicians, students, and anyone interested in the current challenges and perspectives of neurological disorders.
|